STALLERGENES and Protein' eXpert Enter Into a Partnership for Producing Mites Recombinant Allergens
... treatments, STALLERGENES devotes 18% of its turnover to Research and Development, and in particular ... tablet form. In 2006, STALLERGENES recorded a turnover of 126.5 million euros, half of which on markets ... in North America. The 48-staff company expects a turnover of over EUR3.3 million in 2007 (of which 50% at ...Malaria: New Treatment is Upcoming
... sigma-tau was founded in Italy in 1957 and achieved a global turnover of EUR 665 million ($ 920 million) in 2007. sigma-tau SpA consistently invests 16% of its annual turnover in R&D. sigma-tau's 400 R&D staff are currently running 43 R&D ...Stallergenes Inaugurates the Biggest Pharmaceutical Allergen Production Unit in the World
... desensitisation treatments, Stallergenes devotes 20% in raw data of its turnover to Research and Development and is actively involved in the development of ... class: sublingual desensitisation tablets. In 2007, Stallergenes had a turnover of 147 million euros and provided desensitisation treatments to more than ...Fufeng Announces 2008 Interim Results With Strong Sign of Recovery
... turnover Increased by 45.7% Profit Attributable to Shareholders Increased ... increased sales volume and selling price of major products, the Group's turnover increased to RMB1,630.4 million, representing an increase of 45.7%. The ...Stallergenes: Q2 2008 Sales up 18% Revision Upwards of 2008 Sales Growth
... in sublingual desensitisation treatment, Stallergenes devotes 16% of its turnover to Research and Development and is actively involved in the development of ... class: sublingual desensitisation tablets. In 2007, Stallergenes had a turnover of 147 million euros and provided desensitisation treatments to more than ...Stallergenes : Sublingual Desensitisation Tablets Oralair Grasses Approved in Germany
... in sublingual desensitisation treatments, Stallergenes devotes 18% of its turnover to Research and Development and is actively involved in the development of ... class: sublingual desensitisation tablets. In 2007, Stallergenes had a turnover of 147 million euros and provided desensitisation treatments to more than ...Fufeng Announces 2007 Annual Results
... turnover Increased by 37% HONG KONG, April 22 /Xinhua-PRNewswire/ -- Fufeng Group ... year, driven by the increased sales volume of major products, the Group's turnover increased to RMB2,445.7 million, representing an increase of 37% compared ...Business Opportunities in Spain's Fast-Growing Biotechnology Industry
... The biotechnology sector is one of the most dynamic in Spain. It has maintained an annual growth rate for turnover and job creation of 30% according to data from ASEBIO, the Spanish Association of Bio-companies. Spain attracts international projects and financing ...Next Stage Solutions Announces Three New Financial Services For Emerging Business
... businesses hire a CFO who is not the right fit. The cost of these mistakes is staggering, both in dollars and efficiency: the average rate of CFO turnover at small and midsized companies is merely 20 months; the cost of screening and hiring two CFOs in a 20 month span can reach as high as $800,000, not ...Nature parks can save species as climate changes
... adapt to climate change in the 21st century." The findings show that the biodiversity of particular areas is likely to change significantly. The turnover of species in some sites could be as high as 50 per cent, as established species leave to find more suitable climes or new food supplies, and new ...Poxel SAS Set up to Find Innovative Solutions for Metabolic Diseases Management
... in the US and Europe. It is predicted that more than 300 million patients will have this disease by 2025 (IDF). The market is about EUR bn9.6 turnover in 2007, expected to reach EUR bn15 by 2016. Existing therapies on the market are dominated by few dominant product classes, but significant ...Sinobiopharma Updates on Progress; Projects Increases in Sales and Revenues In 2009
... flagship drug, with business agents who distribute the Company's products in 30 provinces and key major cities throughout China. Total turnover is projected to be more than RMB 105 million (US $15.3 million), of which 70 percent will be Sinobiopharma profit. Sales, ...Novel Once Daily Anti-Epileptic Zebinix(R) Approved in the European Union
... 20 French or Portuguese speaking African countries. Bial is strongly committed to therapeutic innovation investing approximately 20% of its turnover in research and development every year. Key research areas for BIAL are the central nervous system, the cardiovascular system and allergology. Bial ...Mindray Announces 2008 Fourth Quarter and Full Year Results
... Data Average accounts receivable days outstanding was 40 days for the full year 2008 compared to 26 days for the full year 2007. Inventory turnover was 60 days for the full year 2008 compared to 55 days for the full year 2007. Average accounts payable days outstanding was 46 days for the full ...Chronic Lung Disease - Axentis Pharma Attracts Investment Interest
... in the best light to powerful investors. Our lead product ARB-CF0223 - also known as Fluidosome(R) tobramycin - is expected to generate a peak annual turnover of approx. 100 million EUR within five years of market launch. The investment that we will be seeking in early 2010 will see us through until this ...Cosun and Avantium Announce Collaboration
... ago. The cooperative currently has approximately 11,000 member/shareholders. Cosun has grown into a group with an average workforce of 4,300 and a turnover of some EUR 1.7 billion. For more information about Cosun Please visit the website: http://www.cosun.com About Avantium ...Health Robotics Announces Results of the European Union-Sponsored SafeChemo Project
... the Capital Region of Denmark. RAP delivers pharmacy services under GMP regulations to 14 hospitals serving 2,300 wards [nurse stations]. The yearly turnover is EUR200 million, and the 460-staff includes 75 pharmacists and 230 technicians. RAP supports three centers for cancer treatment and prepares ...New uses for imidazolium salts in medicine and alternative energy
... gallate (EGCG), a green tea extract, have been known to slow down or prevent the oxidative process, they also exhibit low potencies and a rapid turnover in the body's metabolism. IBN Principal Research Scientist Lang Zhuo, Ph.D., said, "Our investigations with hepatic stellate cells show that IMSs ...Mindray Medical International Announces Second Quarter 2008 Results
... outstanding was 32 days for the second quarter 2008 compared to 21 days for the second quarter 2007 and 32 days for the first quarter 2008. Inventory turnover was 57 days for the second quarter 2008 compared to 59 days for the second quarter 2007 and 64 days for the first quarter 2008. Average accounts ...SEKAB Agreement: More Verified Ethanol to Europe
... development of technology and production processes for ethanol from cellulose, with a second generation bio-ethanol pilot plant operating since 2004. turnover for 2007 amounted to 2 billion SEK. Head office and pilot plant are in Ornskoldsvik, Sweden. Contact Anders Fredriksson, EVP, SEKAB BioFuels ...Quintiles Named to Computerworld Magazine's '100 Best Places to Work in Information Technology' List
... annual report takes into consideration average salary and bonus increases, the percentage of IT employees receiving promotions, IT staff turnover rates, training and development opportunities and the percentage of women and minorities in IT staff and management positions for US-based ...Scientists fix bugs in our understanding of evolution
... insights into the evolution of DNA and protein sequences. The results challenge our understanding of how evolution happens and suggest that sequence turnover is much more common than assumed. "Evolution is happening so slowly that we cannot study it by simply watching it. That's why we learn about the ...220 Companies Place Switzerland First in Biotech Density Per Capita
... foreign investment agency Location Promotion Switzerland ( http://www.locationswitzerland.com ). "These firms employ 14,000 people and have an annual turnover of 7 billion Swiss francs," he says. "Supporting the industry are more than 300 research groups at universities and other public institutions ...Mindray Medical International Announces First Quarter 2008 Results
... days outstanding was 32 days for the first quarter 2008 compared to 22 days for the first quarter 2007 and 26 days for the full year 2007. Inventory turnover was 64 days for the first quarter 2008 compared to 72 days for the first quarter 2007 and 55 days for the full year 2007. Average accounts payable ...DxTech and Nicholas Piramal in POC Diagnostics Alliance
... by adhering to ethically sound, innovative and value-driven practices in its diverse, yet focused, business ventures and initiatives. The Group's turnover exceeded US$750 million in FY2007. The names of specific Group Companies are to be changed subject to shareholders' and Central Government's ....Lentigen Licenses Fundamental Lentiviral Vector Technology Patent From the University of Cambridge
... licences and 95 consultancy contracts were closed and the company assumed the management of a portfolio of 72 companies in which it holds equity. The turnover from technology and knowledge transfer was 6.0 million pounds of which 5.3 million pounds (88%) was returned to the University's academics and ...